Cargando…
Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
BACKGROUND: There are recommendations regarding the total dose of hydrocortisone to be administered in the treatment of classical congenital adrenal hyperplasia (CAH) to achieve the twin objectives of glucocorticoid replacement and control of hyperandrogenism. However, there is evidence gap regardin...
Autores principales: | Ajish, T. P., Praveen, V. P., Nisha, B., Kumar, Harish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4192987/ https://www.ncbi.nlm.nih.gov/pubmed/25364676 http://dx.doi.org/10.4103/2230-8210.141358 |
Ejemplares similares
-
Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011) -
Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany
por: Dörr, Helmuth G., et al.
Publicado: (2018) -
Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2018) -
Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Lim, Seung Gyun, et al.
Publicado: (2021) -
Characteristics of Growth in Children With Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency During Adrenarche and Beyond
por: Troger, Tobias, et al.
Publicado: (2021)